APA (7th ed.) Citation

Xu, Y., Xu, H., Li, M., Wu, H., Guo, Y., Chen, J., . . . Li, J. (2019). KIAA1199 promotes sorafenib tolerance and the metastasis of hepatocellular carcinoma by activating the EGF/EGFR-dependent epithelial-mesenchymal transition program. Cancer letters, 454, 78-89. https://doi.org/10.1016/j.canlet.2019.03.049

Chicago Style (17th ed.) Citation

Xu, Yanmin, et al. "KIAA1199 Promotes Sorafenib Tolerance and the Metastasis of Hepatocellular Carcinoma by Activating the EGF/EGFR-dependent Epithelial-mesenchymal Transition Program." Cancer Letters 454 (2019): 78-89. https://doi.org/10.1016/j.canlet.2019.03.049.

MLA (9th ed.) Citation

Xu, Yanmin, et al. "KIAA1199 Promotes Sorafenib Tolerance and the Metastasis of Hepatocellular Carcinoma by Activating the EGF/EGFR-dependent Epithelial-mesenchymal Transition Program." Cancer Letters, vol. 454, 2019, pp. 78-89, https://doi.org/10.1016/j.canlet.2019.03.049.